The Evidence and Clinical Rationale for the Use of JAK Inhibitors in the Management of AD . Can Allergy Immunol Today [Internet]. 2022 Nov. 12 [cited 2026 Mar. 20];2(s11):3–11. Available from: https://canadianallergyandimmunologytoday.com/article/view/2-s11-lacuesta_and_lee